Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.75 USD | -1.19% | +4.57% | -29.53% |
Financials (USD)
Sales 2024 * | 599M | Sales 2025 * | 705M | Capitalization | 2.66B |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | 8M | EV / Sales 2024 * | 4.31 x |
Net cash position 2024 * | 80.82M | Net cash position 2025 * | 115M | EV / Sales 2025 * | 3.61 x |
P/E ratio 2024 * |
-50
x | P/E ratio 2025 * |
323
x | Employees | 1,300 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.43% |
Latest transcript on Inari Medical, Inc.
1 day | -1.19% | ||
1 week | +4.57% | ||
Current month | +22.52% | ||
1 month | +18.40% | ||
3 months | -21.71% | ||
6 months | -21.09% | ||
Current year | -29.53% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Hykes
CEO | Chief Executive Officer | 51 | 17-08-31 |
Mitchell Hill
DFI | Director of Finance/CFO | 65 | 19-02-28 |
Norman Nie
CTO | Chief Tech/Sci/R&D Officer | - | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Root
BRD | Director/Board Member | 64 | 11-08-31 |
Don Milder
CHM | Chairman | 70 | 11-08-31 |
Catherine Szyman
BRD | Director/Board Member | 57 | 19-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.94% | 14 M€ | -3.66% | ||
0.15% | 1,085 M€ | +8.83% | - | |
0.09% | 115 M€ | +4.53% | - | |
0.08% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 45.75 | -1.19% | 887,809 |
24-05-16 | 46.3 | -1.47% | 1,113,351 |
24-05-15 | 46.99 | +3.27% | 815,560 |
24-05-14 | 45.5 | -0.18% | 885,041 |
24-05-13 | 45.58 | +4.18% | 1,312,145 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.53% | 2.66B | |
+73.24% | 12.39B | |
-19.09% | 7.89B | |
+5.88% | 6.59B | |
+13.24% | 5.43B | |
+38.48% | 4.96B | |
-17.30% | 4.72B | |
-19.78% | 4.02B | |
+47.29% | 2.37B | |
-2.10% | 1.96B |
- Stock Market
- Equities
- NARI Stock